Terns’ lead candidate has demonstrated “unprecedented data” in chronic myeloid leukaemia, according to analysts.

The somatic genomics approach analyses naturally accumulated genetic mutations within individual patient tissue.

MSD's glut of pipeline-boosting deals in the build-up to a looming patent cliff has continued with a $6.7 billion bid to ...

LOUISVILLE, Ky. (WDRB) -- After hearing from customers, Louisville MSD is delaying and reducing its proposed rate hike. The original proposed 4.9% increase was expected to start this Friday, Aug. 1.

MSD is paying $20 million upfront to activate an alliance with Flagship Pioneering's Quotient Therapeutics that will focus on ...